Vectormune FP ILT

País: Unió Europea

Idioma: espanyol

Font: EMA (European Medicines Agency)

ingredients actius:

recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live

Disponible des:

CEVA-Phylaxia Co. Ltd.

Designació comuna internacional (DCI):

Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Grupo terapéutico:

Pollo

indicaciones terapéuticas:

For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Estat d'Autorització:

Autorizado

Data d'autorització:

2020-12-09

Informació per a l'usuari

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
La información actualizada sobre este medicamento veterinario está
disponible en el sitio web de
información sobre medicamentos veterinarios.

Fitxa tècnica

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
La información actualizada sobre este medicamento veterinario está
disponible en el sitio web de
información sobre medicamentos veterinarios.